ArticleArchives of microbiology2026
Transcriptional regulator Rv2250c affects isoniazid resistance by down-regulating the expression of efflux pump Rv3728 in Mycobacterium tuberculosis.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, is currently resistant to antibiotics and has undergone transcriptional adaptation to them, yet only a few transcription factors regulating mycobacterial drug resistance have been identified. In this study, the transcriptional regulatory protein Rv2250c of the TetR family was found to be a regulatory molecule of INH. Compared with wild-type strains, strains lacking the rv2250c gene showed higher minimum inhibitory concentrations (MICs) and greater intracellular survival in macrophages under INH stress. Furthermore, the INH competition with Rv2250c weakens its interaction with the efflux pump gene rv3728, thereby reducing its negative regulatory effect. This enhances the function of the MTB cell wall efflux pump, reducing the accumulation of ethidium bromide (EtBr) within the bacteria. In summary, we found that Rv2250c can regulate INH susceptibility by modulating the expression of efflux pump-encoding genes.
Indexed as
Identifiers
41945114What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.